ALS2CR4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.357800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.468000E-01
Normal-vs-Stage2
5.399600E-01
Normal-vs-Stage3
8.470400E-01
Normal-vs-Stage4
1.646560E-01
Stage1-vs-Stage2
6.257600E-01
Stage1-vs-Stage3
5.221600E-01
Stage1-vs-Stage4
8.543600E-02
Stage2-vs-Stage3
3.411200E-01
Stage2-vs-Stage4
2.688800E-01
Stage3-vs-Stage4
8.507700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.454800E-01
Normal-vs-AfricanAmerican
3.656000E-01
Normal-vs-Asian
7.295000E-01
Caucasian-vs-AfricanAmerican
6.610200E-01
Caucasian-vs-Asian
6.012800E-01
AfricanAmerican-vs-Asian
4.101800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.051200E-01
Normal-vs-Female
4.542600E-01
Male-vs-Female
4.046200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.347400E-01
Normal-vs-Age(41-60Yrs)
2.835600E-01
Normal-vs-Age(61-80Yrs)
6.749000E-01
Normal-vs-Age(81-100Yrs)
8.156000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.769000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.381600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.723600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.047510E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.149190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.470800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.670400E-01
Normal-vs-Daily Drinker
9.692000E-01
Normal-vs-Weekly Drinker
4.469000E-01
Normal-vs-Occasional Drinker
3.215200E-01
Normal-vs-Social Drinker
4.569000E-01
Non Drinker-vs-Daily Drinker
6.384200E-01
Non Drinker-vs-Weekly Drinker
2.339600E-01
Non Drinker-vs-Occasional Drinker
9.037700E-02
Non Drinker-vs-Social Drinker
1.566410E-01
Daily Drinker-vs-Weekly Drinker
8.166200E-02
Daily Drinker-vs-Occasional Drinker
2.265700E-02
Daily Drinker-vs-Social Drinker
1.076570E-01
Weekly Drinker-vs-Occasional Drinker
7.389200E-01
Weekly Drinker-vs-Social Drinker
7.940800E-01
Occasional Drinker-vs-Social Drinker
9.921000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.884600E-01
Normal-vs-Grade 2
8.419400E-01
Normal-vs-Grade 3
4.514400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.982030E-02
Grade 1-vs-Grade 3
2.338300E-03
Grade 1-vs-Grade 4
9.884600E-01
Grade 2-vs-Grade 3
1.087610E-01
Grade 2-vs-Grade 4
8.419400E-01
Grade 3-vs-Grade 4
4.514400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.546800E-01
Normal-vs-NonDiabetic
5.764000E-01
Diabetic-vs-NonDiabetic
4.567400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.724600E-01
Normal-vs-NoPancreatitis
6.048000E-01
Pancreatitis-vs-NoPancreatitis
9.806200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.644600E-01
Normal-vs-N1
5.259200E-01
N0-vs-N1
9.813800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.366200E-01
Normal-vs-TP53-NonMutant
7.632600E-01
TP53-Mutant-vs-TP53-NonMutant
6.479600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
